EGM
AMRX icon

Engineers Gate Manager’s Amneal Pharmaceuticals AMRX Stock Holding History

Engineers Gate Manager’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100,789
Closed -$1.25M – 2216
2026
Q1 		$1.25M Buy
100,789
+82,939
+465% +$1.11M 0.02% 933
2025
Q4 		$225K Sell
17,850
-72,399
-80% -$828K ﹤0.01% 1760
2025
Q3 		$903K Sell
90,249
-36,478
-29% -$327K 0.01% 1202
2025
Q2 		$1.03M Buy
126,727
+41,105
+48% +$310K 0.01% 1104
2025
Q1 		$718K Buy
85,622
+32,871
+62% +$274K 0.01% 1254
2024
Q4 		$418K Buy
52,751
+36,011
+215% +$302K 0.01% 1542
2024
Q3 		$139K Buy
16,740
+1,620
+11% +$12.7K ﹤0.01% 1870
2024
Q2 		$96K Sell
15,120
-19,020
-56% -$121K ﹤0.01% 1753
2024
Q1 		$207K Buy
+34,140
New +$193K 0.01% 1640
2023
Q1 		– Sell
-17,112
Closed -$34.1K – 1626
2022
Q4 		$34.1K Buy
+17,112
New +$38.4K ﹤0.01% 1578
2021
Q4 		– Sell
-10,009
Closed -$53K – 1988
2021
Q3 		$53K Sell
10,009
-43,305
-81% -$218K ﹤0.01% 1573
2021
Q2 		$273K Sell
53,314
-70,961
-57% -$403K 0.02% 1193
2021
Q1 		$836K Sell
124,275
-10,868
-8% -$60.2K 0.04% 667
2020
Q4 		$618K Buy
135,143
+21,504
+19% +$95.3K 0.03% 850
2020
Q3 		$441K Sell
113,639
-115,738
-50% -$495K 0.02% 1058
2020
Q2 		$1.09M Buy
229,377
+101,813
+80% +$419K 0.06% 566
2020
Q1 		$444K Sell
127,564
-69,708
-35% -$295K 0.03% 834
2019
Q4 		$951K Sell
197,272
-75,924
-28% -$264K 0.04% 668
2019
Q3 		$792K Buy
273,196
+203,469
+292% +$710K 0.04% 613
2019
Q2 		$500K Buy
+69,727
New +$713K 0.03% 720
2018
Q4 		– Sell
-60,698
Closed -$1.35M – 860
2018
Q3 		$1.35M Buy
+60,698
New +$1.28M 0.1% 291

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Engineers Gate Manager's AMRX Position: Q2 2026 in Review

Engineers Gate Manager sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 100,789 shares — an estimated $1.25M sold.

Engineers Gate Manager first reported a position in AMRX in Q3 2018 and held it in 21 quarters. The position peaked at $1.35M in Q3 2018. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Engineers Gate Manager reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Engineers Gate Manager sold 100,789 Amneal Pharmaceuticals shares in Q2 2026, an estimated $1.25M.
  • Engineers Gate Manager first reported a position in Amneal Pharmaceuticals in Q3 2018 and held it in 21 quarters.
  • Engineers Gate Manager's Amneal Pharmaceuticals position peaked at $1.35M in Q3 2018.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.